Naloxone Access Program

About Padagis

Padagis is a specialized generic drug company established in 2021, concentrating on a broad portfolio of extended topical and non-oral products like creams, ointments, gels, foams, and nasal treatments. It leverages expertise in Paragraph IV patent challenges to bring complex generic products to market, aiming to improve affordability and access. The company is actively investing in US manufacturing expansion and has formed strategic partnerships, notably in the naloxone space, to broaden its impact. As a private entity, it operates with a clear commercial-stage business model focused on cost reduction and accessibility in healthcare.

Therapeutic Areas